Cooper N - Search Results

1

Evidence-based management of immune thrombocytopenia: ASH guideline update.

Neunert CE, Cooper N. Neunert CE, et al. Among authors: cooper n. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):568-575. doi: 10.1182/asheducation-2018.1.568. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504359 Free PMC article. Review.

2

Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.

Cooper N. Cooper N. Hematol Oncol Clin North Am. 2009 Dec;23(6):1317-27. doi: 10.1016/j.hoc.2009.09.002. Hematol Oncol Clin North Am. 2009. PMID: 19932436 Review.

3

The long-term impact of rituximab for childhood immune thrombocytopenia.

Cooper N, Bussel JB. Cooper N, et al. Curr Rheumatol Rep. 2010 Apr;12(2):94-100. doi: 10.1007/s11926-010-0090-5. Curr Rheumatol Rep. 2010. PMID: 20425017 Review.

4

Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.

Cook L, Cooper N. Cook L, et al. Among authors: cooper n. Drug Des Devel Ther. 2010 Jul 21;4:139-45. doi: 10.2147/dddt.s8601. Drug Des Devel Ther. 2010. PMID: 20689640 Free PMC article. Review.

5

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia.

Cooper N, Terrinoni I, Newland A. Cooper N, et al. Ther Adv Hematol. 2012 Oct;3(5):291-8. doi: 10.1177/2040620712453596. Ther Adv Hematol. 2012. PMID: 23616916 Free PMC article.

6

A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?

Cooper N. Cooper N. Br J Haematol. 2014 Jun;165(6):756-67. doi: 10.1111/bjh.12889. Epub 2014 Apr 25. Br J Haematol. 2014. PMID: 24761791 Free article. Review.

7

B-cell depletion in immune thrombocytopenia.

Psaila B, Cooper N. Psaila B, et al. Among authors: cooper n. Lancet. 2015 Apr 25;385(9978):1599-601. doi: 10.1016/S0140-6736(14)61930-9. Epub 2015 Feb 5. Lancet. 2015. PMID: 25662418 No abstract available.

8

Mycophenolate mofetil therapy for severe immune thrombocytopenia.

Taylor A, Neave L, Solanki S, Westwood JP, Terrinonive I, McGuckin S, Kothari J, Cooper N, Stasi R, Scully M. Taylor A, et al. Among authors: cooper n. Br J Haematol. 2015 Nov;171(4):625-30. doi: 10.1111/bjh.13622. Epub 2015 Aug 6. Br J Haematol. 2015. PMID: 26250874 Free article.

9

Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.

Michel M, Wasser J, Godeau B, Aledort L, Cooper N, Tomiyama Y, Khellaf M, Wang X. Michel M, et al. Among authors: cooper n. Ann Hematol. 2015 Dec;94(12):1973-80. doi: 10.1007/s00277-015-2485-x. Epub 2015 Sep 4. Ann Hematol. 2015. PMID: 26341755 Clinical Trial.

10

Emperipolesis in a patient receiving romiplostim.

Cooper N, Bain BJ. Cooper N, et al. Am J Hematol. 2016 Jan;91(1):166. doi: 10.1002/ajh.24199. Epub 2015 Nov 17. Am J Hematol. 2016. PMID: 26407183 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,321 results

Search Page